Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber

High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: A double-blind, placebo-controlled study

(2012) Ulrich Wahn et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Recombinant Bet v 1 vaccine for treatment of allergy to birch pollen

(2011) Hans Grönlund et al.   Human vaccines & immunotherapeutics

Recombinant allergens for specific immunotherapy

(2011) Oliver Cromwell et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccination

(2011) Susanne Vrtala et al.   VACCINE

Evaluating the Effects of Testing Period on Pollinosis Symptoms Using an Allergen Challenge Chamber

(2011) Ayumi Yuki et al.   ALLERGOLOGY INTERNATIONAL

The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy

(2010) P. Devillier et al.   ALLERGY

Mometasone Furoate Nasal Spray Provides Early, Continuing Relief of Nasal Congestion and Improves Nasal Patency in Allergic Patients

(2010) Anne Marie Salapatek et al.   American Journal of Rhinology & Allergy

Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis

(2010) Peter Couroux et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Efficacy, safety, and immunological effects of a 2-year immunotherapy with Depigoid® birch pollen extract: a randomized, double-blind, placebo-controlled study

(2010) A.-S. Höiby et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions

(2010) J. M. Hohlfeld et al.   CLINICAL AND EXPERIMENTAL ALLERGY

GA2LEN skin test study I: GA²LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe

(2009) L. M. Heinzerling et al.   ALLERGY

Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects

(2009) J. L. Ceuppens et al.   CLINICAL AND EXPERIMENTAL ALLERGY

The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber

(2009) Friedrich Horak et al.   INFLAMMATION RESEARCH

Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber

(2009) Friedrich Horak et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives

(2008) A. Purohit et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis

(2008) Gabrielle Pauli et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY